Active, not recruitingPhase 1NCT04670068

Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
UNC Lineberger Comprehensive Cancer Center
Principal Investigator
Linda Van Le, MD, MD
UNC
Intervention
CAR.B7-H3(drug)
Enrollment
4 target
Eligibility
18 years · All sexes
Timeline
20212030

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04670068 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials